MyMD Pharmaceuticals Financials

MyMD Pharmaceuticals Stock Summary

MyMD Pharmaceuticals competes with Recursion Pharmaceuticals, Atea Pharmaceuticals, Unity Biotechnology, Replimune, and Nuvectis Pharma. MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company was founded in 2014 and is headquartered in Baltimore, Maryland. Mymd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.

MyMD Pharmaceuticals Key Financial Ratios

MyMD Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MyMD Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare MyMD Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MyMD Pharmaceuticals competition to find correlations between indicators driving MyMD Pharmaceuticals's intrinsic value. More Info.MyMD Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value MyMD Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

MyMD Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of MyMD Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MyMD Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of MyMD Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing MyMD Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MyMD Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.